Alternative vaccine strategies to prevent serogroup B meningococcal diseases.
Poolman
J
J
GlaxoSmithKline Biologicals, Bacterial vaccines, Rue de l'institut, 89, B-1330, Rixensart, Belgium.
Berthet
F X
FX
D000818:Animals; D004926:Escherichia coli / Q000235:genetics; D006801:Humans; D008589:Meningococcal Infections / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000276:immunology*; D009345:Neisseria meningitidis / Q000145:classification / Q000235:genetics; D012703:Serotyping; D014614:Vaccines, Synthetic / Q000276:immunology
D022401:Meningococcal Vaccines; D014614:Vaccines, Synthetic